| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $16K | -15.2% |
| R&D Expense | $490K | +50.7% |
| SG&A Expense | $460K | +28.2% |
| Operating Income | -$3.3M | -9.5% |
| Net Income | -$3.9M | -22.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $27K | -95.7% |
| Total Assets | $288K | -68.0% |
| Current Liabilities | $3.0M | +24.6% |
| Total Liabilities | $3.1M | +21.9% |
| Stockholders' Equity | -$2.8M | -71.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.9M | -24.0% |
| Capital Expenditures | $58K | — |
| Investing Cash Flow | -$58K | — |
| Financing Cash Flow | $2.3M | -14.5% |
| Free Cash Flow | -$2.9M | — |